Literature DB >> 2098173

Growth and differentiation factors: role in bone induction and potential application in craniofacial surgery.

L J Marden1, A H Reddi, J O Hollinger.   

Abstract

Repair of craniofacial bone often requires autogenous or allogeneic bone. Natural materials deliver bone-inducing substances to wound beds and provide scaffolding for osteoconduction, but not without risk of morbidity. We are developing a synthetic material consisting of proteins which stimulate bone repair encased within a moldable, biodegradable delivery system. The stages of bone induction include chemoattraction of stem cells, proliferation and differentiation of these cells to competent chondrocytes and osteoblasts, angiogenesis, mineralization, and remodeling. Bovine osteogenin induces bone formation in soft tissue in rats, and accelerates bone repair in cranial defects. The protein has been purified and partially sequenced. Growth factors may augment the inductive effects of osteogenin by attracting preosteoblasts, accelerating their proliferation, and stimulating angiogenesis. A composite material of osteogenin and growth factors released from a biodegradable delivery system in a time-dependent fashion is proposed to decrease the necessity for autogenous and allogeneic bone implants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2098173

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Combinatorial growth of oxide nanoscaffolds and its influence in osteoblast cell adhesion.

Authors:  Claudia Y Acevedo-Morantes; Roberto A Irizarry-Ortiz; Pablo G Caceres-Valencia; Surinder P Singh; Jaime E Ramirez-Vick
Journal:  J Appl Phys       Date:  2012-05-17       Impact factor: 2.546

2.  Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects.

Authors:  L J Marden; R S Fan; G F Pierce; A H Reddi; J O Hollinger
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.